Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment

Risk of hepatitis B for travelers: is vaccination for all travelers really necessary?

Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: Immigration and Chagas disease in Barcelona (Spain)

A 2-year entomological study of potential malaria vectors in central Italy" E-pub ahead of print in Vector-borne and Zoonotic diseases"

Crimean-Congo hemorrhagic fever, south-western Bulgaria

The risk of malaria in travelers to India

Serum Cross-Reactive Antibody Response to a Novel Influenza A (H1N1)v Virus after Vaccination with Seasonal Influenza Vaccine

Serum Cross-Reactive Antibody Response to a Novel Influenza A (H1N1)v Virus after Vaccination with Seasonal Influenza Vaccine

Influenza  A(H1N1) - Serum Cross-Reactive Antibody Response to a Novel Influenza A (H1N1) Virus after Vaccination with Seasonal Influenza Vaccine

The origin of the new Influenza A (H1N1)-swl and its antigenic properties

The origin of the new Influenza A (H1N1)-swl and its antigenic properties

Influenza  A(H1N1) - The origin of the new Influenza A (H1N1)-swl and its antigenic properties

Patients needing hospital care because of the new influenza A(H1N1) infection – implications for mitigation strategies

Patients needing hospital care because of the new influenza A(H1N1) infection – implications for mitigation strategies

Influenza  A(H1N1) - Patients needing hospital care because of the new influenza A(H1N1) infection – implications for mitigation strategies

Influenza  A(H1N1) - Pandemic potential of a strain of influenza A (H1N1): early findings

Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans in the United States

Pandemic potential of a strain of influenza A (H1N1): early findings

Influenza vaccination in the elderly: current evidence and uncertainties

Pandemic Influenza – Modelling - Population-based simulation of influenza pandemics: validity and significance for public health policy

Avian Influenza – Africa - Highly pathogenic avian influenza virus H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates

Use of Personal Protective Equipment and risk of symptoms and infection with low pathogenicity Avian Influenza A(H7N3)

Dose sparing strategy with intradermal influenza vaccination – a possible way of ‘stretching’ vaccine in a pandemic. A trial in patients with solid cancer

Impact of universal influenza vaccination policy in Ontario and its implications for vaccination policies in Europe

Use of antigens derived from plants to produce recombinant influenza vaccines opens new ways of pandemic influenza vaccine development

Trials and Tribulations

Investigation of the temporal association of Guillain-Barre´ Syndrome with influenza vaccine and influenza-like illness

A Series of publications on oseltamivir resistance in seasonal influenza – A(H1N1-H247Y)

Treatment

Comparison of three different papers about modelling features in a pandemic influenza scenario